MedTrace Logo

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

NCT01542333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue and urine from patients with cancer in the laboratory may help doctor learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in samples from younger patients with Wilms tumor.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

proteomic profiling

GENETIC

reverse transcriptase-polymerase chain reaction

GENETIC

western blotting

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

spectroscopy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Harold N. Lovvorn, III, MD · Vanderbilt Children's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542333 on ClinicalTrials.gov